Form 4: Brown-Forman Executive Granted Stock Appreciation Rights
Insider Transaction Report
Michael Andrew Masick, EVP/President of Americas at Brown-Forman Corp, was granted 28,418 Stock Appreciation Rights with an exercise price of $31.15.
Summary
- Michael Andrew Masick, Executive Vice President and President of Americas for Brown-Forman Corp (BFA, BFB), was granted 28,418 Stock Appreciation Rights (SARs).
- The SARs have an exercise price of $31.15 per underlying Class B Common share.
- These SARs were acquired on July 24, 2025, and become exercisable on May 1, 2028.
- The expiration date for these Stock Appreciation Rights is April 30, 2035.
- Following this transaction, Michael Andrew Masick beneficially owns 28,418 Stock Appreciation Rights directly.
Sentiment
Score: 7
Explanation: The filing reports a routine executive compensation grant, which is generally viewed as a neutral to slightly positive event as it aligns executive incentives with shareholder value, without indicating any significant new operational or financial developments.
Positives
- The grant of Stock Appreciation Rights aligns the executive's financial interests with the long-term performance of Brown-Forman's stock, incentivizing value creation for shareholders.
Future Outlook
The Stock Appreciation Rights are a forward-looking compensation instrument, with their value to the executive dependent on the future appreciation of Brown-Forman's Class B Common stock above the $31.15 exercise price by the expiration date of April 30, 2035.
Industry Context
The grant of Stock Appreciation Rights is a common practice in executive compensation across various industries, including the consumer staples and beverage sector, designed to incentivize long-term performance and align management interests with shareholder returns.
Comparison to Industry Standards
- Stock Appreciation Rights (SARs) are a widely adopted form of equity compensation in publicly traded companies, including those in the consumer staples and beverage sectors.
- This filing does not provide specific benchmarks or comparative data against industry peers such as Diageo plc, Pernod Ricard SA, or Constellation Brands, Inc., to assess the relative competitiveness or generosity of this particular grant.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Application | The grant of Stock Appreciation Rights to a senior executive is consistent with Brown-Forman's established executive compensation policies and corporate governance practices regarding incentive alignment. | 07/24/2025 | Reinforces the company's strategy of using equity-based incentives to motivate long-term performance from its leadership. |
Related Party Transactions
- Grant of 28,418 Stock Appreciation Rights to Michael Andrew Masick, an executive of the company, as part of his compensation package.
Stakeholder Impact
- Shareholders: The grant of SARs aims to align the executive's interests with shareholder value creation, as the SARs' value increases with the company's stock price appreciation.
- Employees: This specific filing does not directly impact the broader employee base beyond the named executive.
Next Steps
- The Stock Appreciation Rights will become exercisable on May 1, 2028, allowing the executive to potentially benefit from stock price appreciation.
Key Dates
| Date | Description |
|---|---|
| 07/24/2025 | Date of acquisition of Stock Appreciation Rights by Michael Andrew Masick. |
| 07/25/2025 | Date the Form 4 filing was signed and submitted. |
| 05/01/2028 | Date when the Stock Appreciation Rights become exercisable. |
| 04/30/2035 | Expiration date of the Stock Appreciation Rights. |
Recommendation
holdThe filing reports a routine grant of Stock Appreciation Rights to a senior executive, which is a standard component of compensation and does not provide new information that would alter the investment thesis for Brown-Forman Corp. It is a non-event for immediate stock price movement.
Keywords
Brown-Forman, BFA, BFB, Stock Appreciation Rights, SARs, Executive Compensation, Insider Transaction, Form 4, Michael Masick
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.